FDA Approves Lerodalcibep Autoinjector for Hypercholesterolemia, Updated Indication

The FDA has approved the Lerodalcibep autoinjector for treating hypercholesterolemia with an updated indication, expanding treatment options for patients with this condition in the United States.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.